Neutrophil-lymphocyte ratio and prediction of pathological complete response to neoadjuvant treatment in breast cancer.

被引：0
|
作者：
Clarke, Rachel
Lucas, Mairi
Ryan, Niamh
Walsh, Siun
Mahon, Sarah
Kelly, Catherine Margaret
机构：
[1] Mater Misercordiae Univ Hosp, Dublin, Ireland
[2] Royal Coll Surgeons Ireland, Dublin, Ireland
[3] Mater Misericordiae Univ Hosp, Dublin 7, Ireland
[4] Mater Misercordiae Univ Hosp, Dept Pathol, Dublin, Ireland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12627
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer
    Koh, C-H
    Bhoo-Pathy, N.
    Ng, K-L
    Jabir, R. S.
    Tan, G-H
    See, M-H
    Jamaris, S.
    Taib, N. A.
    BRITISH JOURNAL OF CANCER, 2015, 113 (01) : 150 - 158
  • [32] Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Predicting Complete Pathological Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
    Karaca, Mustafa
    Salim, Ece
    Alemdar, Mustafa Serkan
    Karaca, Ozge Deniz
    Arici, Mustafa Ozgur
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [33] Early changes of platelet-lymphocyte ratio correlate with neoadjuvant chemotherapy response and predict pathological complete response in breast cancer
    Dan, Jiaqiang
    Tan, Jingya
    Huang, Junhua
    Yuan, Zhiying
    Guo, Yao
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 19 (05)
  • [34] Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio are not predictive of Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
    de Pinho, I. Soares
    Barroso, T.
    Trabulo, C.
    Campoa, E.
    Patel, V.
    Goncalves, L.
    Araujo, J.
    Monteiro, C.
    Ferreira, A.
    Machado, B.
    Damaso, S.
    Luz, P.
    de Sousa, R. Teixeira
    Costa, L.
    BREAST, 2023, 68 : S77 - S77
  • [35] Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy
    Kim, Tae Gyu
    Park, Won
    Kim, Hakyoung
    Choi, Doo Ho
    Park, Hee Chul
    Kim, Seok-Hyung
    Cho, Yong Beom
    Yun, Seong Hyen
    Kim, Hee Cheol
    Lee, Woo Yong
    Lee, Jeeyun
    Kang, Ki Mun
    TUMORI JOURNAL, 2019, 105 (05): : 434 - 440
  • [36] The predictive and prognostic values of neutrophil-lymphocyte ratio in inflammatory breast cancer
    Al Jarroudi, O.
    Zaimi, A.
    Jaouani, L.
    Chibani, H.
    Brahmi, S. A.
    Afqir, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S343 - S343
  • [37] Neutrophil-lymphocyte ratio (NLR) as a prognostic factor in metastatic breast cancer
    Ayala de la Pena, F.
    Yufera Soler, J. C.
    Ivars, M. A.
    Fernandez Sanchez, A.
    Navarro Manzano, E.
    De la Morena Barrio, P.
    Garcia-Garre, E.
    Garcia-Martinez, E.
    Marin Zafra, G.
    Salguero Aguilar, R.
    Garcia, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] Prognostic value of pretreatment neutrophil-lymphocyte ratio in metastatic breast cancer
    Mazouz, A.
    Adil, N.
    Chakib, N.
    Samia, A.
    Nawfel, M.
    BREAST, 2015, 24 : S80 - S80
  • [39] A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy
    Ma, Rulan
    Wei, Wanzhen
    Ye, Haixia
    Dang, Chengxue
    Li, Kang
    Yuan, Dawei
    BMC CANCER, 2023, 23 (01)
  • [40] A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy
    Rulan Ma
    Wanzhen Wei
    Haixia Ye
    Chengxue Dang
    Kang Li
    Dawei Yuan
    BMC Cancer, 23
12345